Immatics NV (IMTX)
7.58
-0.22
(-2.82%)
USD |
NASDAQ |
Nov 21, 16:00
7.586
+0.01
(+0.08%)
After-Hours: 20:00
Immatics Shareholders Equity (Quarterly): 427.24M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 427.24M |
| June 30, 2024 | 415.78M |
| March 31, 2024 | 432.81M |
| December 31, 2023 | 248.81M |
| September 30, 2023 | 262.24M |
| June 30, 2023 | 237.14M |
| March 31, 2023 | 218.18M |
| December 31, 2022 | 228.60M |
| September 30, 2022 | 111.11M |
| June 30, 2022 | 130.51M |
| Date | Value |
|---|---|
| March 31, 2022 | 129.46M |
| December 31, 2021 | 27.24M |
| September 30, 2021 | 40.78M |
| June 30, 2021 | 90.97M |
| March 31, 2021 | 109.83M |
| December 31, 2020 | 107.48M |
| September 30, 2020 | 142.83M |
| June 30, 2020 | -77.04M |
| December 31, 2019 | -46.88M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-77.04M
Minimum
Jun 2020
432.81M
Maximum
Mar 2024
170.37M
Average
130.51M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Affimed NV | 19.21M |
| InflaRx NV | 72.91M |
| BioNTech SE | 21.35B |
| CureVac NV | 809.41M |
| ATAI Life Sciences NV | 145.72M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 644.71M |
| Total Liabilities (Quarterly) | 217.47M |
| Current Ratio | 3.978 |